C. Brendan Montano, MDPrivate Practice, Internal Medicine
*Review available screening tests for patients who may have generalized anxiety disorders (GAD).
*Summarize the diagnostic process for patients who may have GAD.
*Outline current and emerging therapeutic options – both pharmacologic and nonpharmacologic – for the optimal management of GAD.
GAD is one of the most common psychiatric conditions that primary care physicians may encounter, characterized by excessive fear and anxiety as well as concomitant behavioral impairments. It is a chronic, disabling condition that may be associated with multiple health problems, yet it remains under-recognized and under-treated. This may result in significant personal, social, and occupational impairment for affected individuals. Oftentimes, patients do not present to the clinic with chief concerns that suggest an underlying diagnosis of GAD. For example, symptoms may be musculoskeletal, cardiac, or gastrointestinal. Furthermore, clinical evidence surrounding treatments for GAD has expanded over the past several years, providing multiple treatment options for clinicians to stay abreast to reduce the burden on their affected patients. Join a leading psychiatrist as he provides expert insights on using best practice recommendations in the primary care setting to effectively screen, diagnose and treat patients with GAD.
This event is sponsored by Clinical Care Solutions and is not sponsored by industry.